https://www.pharmamanufacturing.com/industry-news/news/11299831/biocon-and-mylan-nab-fda-approval-for-herceptin-biosim
Biocon and Mylan nab FDA approval for Herceptin biosim | Pharma Manufacturing
Co-developed by both companies, Ogivri will be used for the treatment of breast and gastric cancer patients.
fda approvalbioconmylannab